Agilio ('the Company'), a leading UK frontline healthcare operations software provider, today announced a strategic growth investment from Five Arrows, the alternative assets arm of Rothschild & Co., and TA Associates ('TA'), a leading global private equity firm, to support the next phase of the Company's ambitious expansion plans.
Agilio offers a comprehensive suite of best-of-breed products that help healthcare professionals automate and optimise critical operational functions, such as workforce management, compliance and clinical assets tracking. Since its founding in 2019, the Company has established itself as a market leader in the UK dental and primary care sectors, with many of the top ten dental groups and Integrated Care Board areas using an Agilio system to enhance operations, drive productivity and increase efficiency.
'In the four years since our inception, with support from founding investor August Equity, we have realised our vision of introducing professional, integrated solutions into frontline healthcare settings,' said Dr. Sati Sian, Agilio Chairman. 'We are now ready to scale up further and are delighted to welcome two world-class investors in the form of Five Arrows and TA to support us on the next stage of our journey.'
'Our user-friendly, integrated systems are helping thousands of under-pressure frontline healthcare providers work more efficiently every day,' added Neil Laycock, Agilio CEO. 'This partnership with Five Arrows and TA will help us deliver new products and services for our core UK and Netherlands markets as we continue to expand into new customer sectors. We also plan to expand into multiple new countries where we believe there is strong demand for our solutions.'
Both TA and Five Arrows have global expertise and a proven track record of successfully scaling healthcare technology companies. Their investment will support Agilio to: Bolster product development and innovation, enhancing value for its customers.
Expand into new verticals beyond primary care, dental and veterinary.
Accelerate international growth, following its first expansion into Europe with an acquisition in the Netherlands in 2022.
'We have tracked Agilio for several years and have been deeply impressed by the Company's journey thus far. Through several strategic acquisitions and a continued commitment to innovation, Agilio has built a market-leading software platform that improves patient care and meets the evolving needs of healthcare providers,' said Naveen Wadhera, Managing Director at TA. 'Agilio is well-positioned to further strengthen its suite of solutions and expand its geographic footprint. We are delighted to support the Company on the next chapter of its growth as it looks to further enhance its user experience,' added Kunal Pandit, Managing Director at Five Arrows.
'The leadership team at Agilio has done a fantastic job in growing the business into the UK's leading healthcare operations software provider,' said Mike Biddulph, Partner at August Equity. 'It has been a privilege to support them on their initial journey and achieve such strong and dynamic growth. We are confident that the business will continue to thrive under the stewardship of Five Arrows and TA.'
The financial terms of the investment were not disclosed.
About Agilio Software
Agilio Software is a UK market leader in frontline healthcare operations software; many GPs in England use an Agilio system and it works with many of the top 10 Dental Service Organisations (DSOs). Its mission is to free up time for patient care by digitising critical operational functions such as people management, compliance and clinical asset tracking. It has recently expanded into the veterinary sector and in 2022 completed its first international acquisition, in the Netherlands.
About Five Arrows
Five Arrows is the alternative assets arm of Rothschild & Co and has EUR26 billion AuM with offices in Paris, London, New York, Los Angeles, San Francisco and Luxembourg. With over EUR9 billion of assets under management, the corporate private equity business of Five Arrows is focused on investing in companies with highly defensible market positions; strong management teams; business models with high visibility of organic unit volume growth and strong unit economics and multiple operational levers that can be used to unlock latent value. Sectors are limited to data & software, technology-enabled business services and healthcare.
About TA
TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its five target industries-technology, healthcare, financial services, consumer and business services. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has over 150 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai and Hong Kong.
Contact:
Tel: 0330 236 8399
Email: sme.sales@agiliosoftware.com
ROTHSCHILD & CO 
